| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | PCRX Pacira Biosciences, Inc. | Cross Shawn58 | Chief Financial Officer | Sell | 25,000 | $25.07 | $626,751.44 | -18.2% | -10.9% | - | |
| Dec 10, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $479.17 | $3,833,374.18 | -50.8% | +10.6% | - | |
| Dec 9, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Daniell Richard | Exec. VP, European Commercial | Sell | 115,468 | $28.68 | $3,311,125.73 | -70.5% | +10.3% | - | |
| Dec 9, 2025 | HIMS Hims & Hers Health, Inc. | Perez Garcia Andrea G | Director | Sell | 2,500 | $39.17 | $97,925.00 | -3.0% | -44.3% | - | |
| Dec 9, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Sabag Mark | See "remarks" | Sell | 216,892 | $28.73 | $6,230,754.39 | -51.6% | +10.3% | - | |
| Dec 9, 2025 | BIOA Bioage Labs, Inc. | Rubin Paul D | Chief Medical Officer | Sell | 18,000 | $12.00 | $216,000.00 | -100% | +63.5% | - | |
| Dec 9, 2025 | UTHR United Therapeutics Corp | Mesa Nilda47 | Director | Sell | 187 | $481.63 | $90,064.83 | -3.4% | +11.2% | - | |
| Dec 9, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 4,808 | $40.10 | $192,780.84 | -5.0% | +27.7% | - | |
| Dec 9, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 175,124 | $0.18 | $32,125.05 | -1.3% | - | - | |
| Dec 8, 2025 | UTHR United Therapeutics Corp | Edgemond James45 | CFO And Treasurer | Sell | 21,000 | $478.60 | $10,050,597.03 | -11.0% | +10.4% | - | |
| Dec 8, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Ragosa Mark | Chief Financial Officer | Sell | 42,841 | $41.49 | $1,777,473.09 | -58.0% | +12.6% | - | |
| Dec 8, 2025 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 17,600 | $48.17 | $847,855.20 | -7.6% | -22.2% | - | |
| Dec 8, 2025 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 4,376 | $159.65 | $698,615.27 | -9.2% | -16.2% | - | |
| Dec 8, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $478.58 | $10,768,000.50 | -100% | +10.4% | - | |
| Dec 8, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $483.76 | $3,870,056.43 | -49.1% | +10.4% | - | |
| Dec 5, 2025 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 21,984 | $11.97 | $263,077.09 | -10.0% | -29.1% | - | |
| Dec 5, 2025 | ANIP Ani Pharmaceuticals Inc | Tannenbaum Renee P55 | Director | Sell | 1,800 | $81.15 | $146,070.00 | -6.7% | -7.5% | - | |
| Dec 5, 2025 | GTBIF Green Thumb Industries Inc. | Barnes Dawn Wilson | Director | Sell | 3,500 | $6.60 | $23,100.00 | -5.6% | - | - | |
| Dec 5, 2025 | COLL Collegium Pharmaceutical, Inc | Balice-Gordon Rita J. | Director | Sell | 3,650 | $47.03 | $171,673.37 | -6.5% | -22.1% | - | |
| Dec 4, 2025 | BIOA Bioage Labs, Inc. | Rubin Paul D | Chief Medical Officer | Sell | 68,897 | $10.19 | $701,908.86 | -100% | +100.7% | - | |
| Dec 4, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $477.64 | $3,821,130.43 | -52.0% | +1.3% | - | |
| Dec 4, 2025 | PAHC Phibro Animal Health Corp | Bendheim Jack49 | President And CEO | Sell | 7,040 | $41.00 | $288,606.65 | -4.4% | +27.4% | - | |
| Dec 3, 2025 | ALKS Alkermes Plc. | Hopkinson Craig C.54 | EVP R&D, Chief Medical Officer | Sell | 3,748 | $30.00 | $112,447.12 | -5.4% | -1.1% | - | |
| Dec 3, 2025 | NBIX Neurocrine Biosciences Inc | Lyons Gary A54 | Director | Sell | 15,000 | $152.61 | $2,289,082.50 | -11.1% | -13.7% | - | |
| Dec 3, 2025 | PLNH Planet 13 Holdings Inc. | Wren Chris | VP Of Operations | Sell | 155,500 | $0.19 | $29,202.05 | -1.7% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.